A Virus With Multiple Personalities
Mpox isn't one simple infection. The virus comes in different versions, called clades (KLAYDZ) and subclades, that behave very differently from one another.
Scientists analyzed 3,450 high-quality mpox virus genomes — the complete genetic blueprints of the virus — collected from 24 African countries. What they found was striking: four distinct versions of the virus were circulating at the same time, often crossing national borders.
Think of it like tracking four different weather systems moving across a continent at once. Each one has its own speed, direction, and intensity.
Why the Same Disease Acts So Differently
One version, called Subclade Ia, is largely driven by animal-to-human transmission — meaning people are catching it mainly from infected wildlife, not from other people. This version shows high genetic diversity, suggesting it has been quietly circulating in animal reservoirs in Central Africa for a long time.
But Subclade Ib is different and more concerning. It shows signs of sustained human-to-human spread across Eastern and Southern Africa. That means it doesn't need an animal host to keep going — people are passing it directly to other people, allowing it to travel further and faster.
Clade IIa, found mainly in West Africa, remains largely an animal-to-human infection. Clade IIb, however, is showing a mixed pattern — zoonotic spillovers (jumps from animals to people) alongside sustained human outbreaks in specific genetic lineages.
Borders Don't Stop a Virus
The genetic data also revealed something that public health officials already suspected but could now prove: mpox is crossing international borders constantly.
Phylogeographic (FY-lo-jee-oh-GRAF-ik) analysis — a method that traces viral family trees across geography — showed that the Democratic Republic of the Congo and Sierra Leone appear to be major sources of outbreaks spreading to neighboring countries. Borders between Cameroon and Nigeria, and between the Central African Republic and both Cameroon and DRC, were especially active zones for cross-border spillover.
Human mobility corridors — the routes people commonly travel — closely matched the paths the virus took. In other words, where people move, the virus moves with them.
This research doesn't mean mpox is uncontrollable — it means we now have a clearer map of how to fight it.
What the Science Says
This was a retrospective genomic surveillance study, not a clinical trial. Researchers analyzed existing viral samples from 24 African Union Member States and used computational tools to reconstruct transmission histories. No experimental treatments were tested. The power of this study is in scale — 3,450 genomes is far more than any previous African mpox analysis.
The study also identified a genetic quirk that affects testing accuracy. The mpox virus shows patterns consistent with APOBEC3 editing — a natural human immune process that mutates the virus's genetic code. Standard diagnostic tests may misread these mutations, potentially producing false negatives. The researchers call for "APOBEC3-aware triage," meaning updated lab protocols that account for this.
If you or someone you know is traveling to affected regions in Central, Eastern, or Western Africa, awareness matters. Mpox can spread through close contact with infected people or animals, and through contact with contaminated materials.
Vaccination is available in some settings. If you are in a high-risk area or have had close contact with a confirmed case, talk to your doctor or local health authority about vaccination options. The mpox vaccine is most effective when given before or soon after exposure.
The Limits of What We Know
This study is a snapshot in time and geography. Not all African countries had equal sample representation, and genomic surveillance remains uneven across the continent. Some transmission chains may have been missed simply because samples weren't collected or sequenced.
The Path Forward
Scientists are calling for harmonized (coordinated) genomic surveillance across Africa — a shared, standardized system so outbreaks can be caught and traced faster. They also advocate for a "One Health" approach that treats human, animal, and environmental health as interconnected.
Targeted vaccine deployment guided by this kind of genetic mapping could help stop local outbreaks before they grow into regional epidemics. The data now exists to do this smarter — the challenge is building the systems to act on it in time.
